Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02437318 |
|---|---|
| Brief Title: | Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. (SOLAR-1) |
| First Submitted : | April 22, 2015 |
| First Submitted that Met QC Criteria : | May 4, 2015 |
| First Posted : | May 7, 2015 (Estimate) |
| Results First Submitted : | June 17, 2019 |
| Results First Submitted that Met QC Criteria : | July 22, 2019 |
| Results First Posted : | August 13, 2019 |
| Certification/Extension First Submitted : | July 24, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | July 24, 2018 |
| Certification/Extension First Posted : | July 26, 2018 |
| Last Update Submitted that Met QC Criteria : | November 17, 2023 |
| Last Update Posted : | November 18, 2023 |